Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Name : Lancet Infectious Diseases

DOI : 10.1016/S1473-3099(25)00093-3

Date : September 2025


Publication URL
https://www.scopus.com/record/display.uri?eid=2-s2.0-105013879091&origin=resultslist&sort=plf-f
Type
Journal
ISSN
14733099
Volume
25
Page
1000-1010